Displaying drugs 2751 - 2775 of 3128 in total
Idanpramine
Experimental
Tetrahydrofolic acid
Tetrahydrofolic acid is a folic acid derivative that is produced from dihydrofolic acid after conversion by dihydrofolate reductase. It is converted into 5,10-methylenetetrahydrofolate by serine hydroxymethyltransferase. It is a soluble coenzyme in many reactions, especially in the metabolism of amino acids and nucleic acids.
Nutraceutical
(10R)-10-formyl-5,8,10-trideazafolic acid
Experimental
Dirlotapide
Dirlotapide is a drug employed in the treatment of obesity in dogs. It is marketed by Pfizer and Zoetis under the brand name, Slentrol, and is not intended for human use.
Investigational
Vet approved
Lometrexol
Lometrexol has been used in trials studying the treatment of Lung Cancer, Drug/Agent Toxicity by Tissue/Organ, and Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Cefcapene
Experimental
Cefodizime
Experimental
3-deoxy-D-lyxo-hexonic acid
Experimental
3-deoxy-D-arabino-hexonic acid
Experimental
Tiracizine
Experimental
Cefalonium
Experimental
Vet approved
Cefetamet
Experimental
Haloxazolam
Experimental
Illicit
Amenamevir
Amenamevir has been used in trials studying the treatment of Herpes Zoster, Herpes Simplex, Herpes Genitalis, and Safety of Amenamevir.
Investigational
Mosapramine
Experimental
L-tyrosinamide
Experimental
Caroxazone
Caroxazone is an antidepressant that has been withdrawn from the market. It is a reversible monoamine oxidase inhibitor (MAOI) of both A and B monoamine oxidase subtypes. However, it presents a five-fold preference for the MAO-B subtype.
Withdrawn
Displaying drugs 2751 - 2775 of 3128 in total